• 9 May 2018

    City Office WTC AB shares divested

    Atnotera Group has divested all shares in City Office WTC AB to World Trade Center in Gothenburg AB, it will proceed in two steps.
  • 29 November 2017

    Listing of Atvexa on Nasdaq First North

    The Board of Atvexa AB (publ) ("Atvexa", "The Company", "The Group" or "Atvexa Group"), one of the leading players in the education market in Sweden, has together with Selling Shareholders1 decided to implement a proprietary spread of the Company's shares through a sale of new and existing Class B shares ("Offer"). The Board of Atvexa has therefore applied for listing of the Company's B-shares on Nasdaq First North. The prospectus is published today and the first trading day is expected to be December 13, 2017.
    > Read more about Listing of Atvexa on Nasdaq First North
  • 28 August 2017

    Atnotera AB has become a partner in Nolhaga Hem AB

    The acquisition has evolved through a rights issue which gives Atnotera 39% of the stocks in Nolhaga Hem. Nolhaga Hem is a new store chain within home textiles and interiors. The company headquarters is based in Alingsås, the first store will open in Trollhättan in September and the second store in Alingsås mall of Storken in October.
  • 11 October 2016

    Atnotera AB has acquired a holding in the British company My Clinical Outcomes Ltd.

    This acquisition was carried out as a subscription for a new issue, which gave Atnotera AB a 12% stake in My Clinical Outcomes Ltd. My Clinical Outcomes Ltd (MCO) helps healthcare organisations collect and analyse outcomes that matter to patients. MCO is accredited by the Private Healthcare Information Network (PHIN) to help UK private hospitals meet the requirements set by the Competition & Markets Authority to collect and publish outcomes data.
  • 23 March 2016

    Atnotera AB has, through the subsidiary MLPW Invest AB acquired a holding in Center for Translational Research AB

    This acquisition was carried out as a subscription for a new issue, which gave MLPW a 33% stake in the Center for Translational Research AB CTC Clinical Trial Consultants AB secures expansion capital CTC has recently completed a private placement to secure capital for further expansion of the business and in connection with this, formed a holding company named Center for Translational Research AB, which owns 100% of CTC AB.
  • 25 August 2015

    Atnotera AB has, through subsidiaries, acquired a holding in Fenix Begravning AB.

    This acquisition was carried out in a combination of share purchase and subscription for a new issue, which gave the Atnotera group a 25% stake in the Fenix Begravning AB. Fenix offers its customers a simple funeral planning and booking procedure online, over the phone or through a home call. Fenix provides a straightforward process with full control of the expenses at all the stages, focusing on simplicity, security and quality. The prices are competitive, it is easy to compare the options and the customer is always aware of what s/he is paying for.
  • 1 June 2014

    Atnotera AB has through subsidiaries signed a new issue in the City Office in the WTC AB.

    The issue gives Atnotera group 50 % stake in the City Office. City Office of the World Trade Center has pushed office space and office services since 1990. The company works with companies of all sizes. Our tenants and virtual clients include many successful Swedish and international companies .
  • 30 April 2013

    Atinvestera acquires shares in Global Hand Surgery Clinics AB

    Atinvestera in Stockholm AB has acquired 1/3 of the shares of Global Hand Surgery Clinic AB. The Company is engaged in hand surgery, with three clinics; Hand center Gothenburg, Hand center Stockholm and Hand center Malmö. All Hand Centers units are complete clinics for hand surgery and investigates and treats all diagnoses in hand surgery. Employees at the clinics are all specialists in hand surgery with broad experience in both elective and emergency hand surgery.
  • 14 April 2013

    Vårdapoteket sold to Apoteket Hjärtat

    VAINAB together with Priveq Investment and Investor Growth Capital entered into an agreement with Apotek Hjärtat to divest in Vårdapoteket i Norden AB (Vårdapoteket)
  • 6 February 2013

    Atvexa – New board member

    The annual general meeting of Atvexa AB appoints a new board member. At the annual general meeting of Atvexa the 6th of February 2013, Cecilia Daun Wennborg was appointed as new board member. The board constitutes since before of Eva Person, Lars Brune and Peter Weiderman.